CLL at ASH 2014: Expert discussion
CLL at ASH 2014: Expert discussion
IBIS-I trial: tamoxifen lowered breast cancer rates among high-risk women
Checkpoint inhibitors show safety and efficacy in Hodgkin lymphoma
Predicting the relapse of acute myeloid leukaemia with genetic screening
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients
Early events found to trigger lung cancer twenty years before diagnosis
Potential role of blood testing for microRNA profiles in paediatric cancers
Cancer genomics and pancreatic cancer
Breast cancer in young women in Mexico
Red wine and other food-derived agents to prevent cancer
Comment: NCRI 2014 conference – Highlights and the future
Malignant brain tumours and the role of genetically engineered mice models